Last update 21 Nov 2024
BYON-4413
Last update 21 Nov 2024
Overview
Basic Info
Drug Type Antibody drug conjugate (ADC) |
Synonyms |
Target |
Mechanism CD123 modulators(Interleukin-3 receptor subunit alpha modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Login to view timeline
Structure
Molecular FormulaC11H22N4O4 |
InChIKeyAGGWFDNPHKLBBV-YUMQZZPRSA-N |
CAS Registry159858-33-0 |
View All Structures (2)
Boost your research with our ADC technology data.
login
or
Related
1
Clinical Trials associated with BYON-4413A First-in-human Dose Escalation and Expansion Trial With the Antibody-drug Conjugate BYON4413 to Evaluate Safety, Pharmacokinetics, and Preliminary Efficacy in Patients With Relapsed/Refractory Acute Myeloid Leukemia or Myelodysplastic Neoplasms.
100 Clinical Results associated with BYON-4413
Login to view more data
100 Translational Medicine associated with BYON-4413
Login to view more data
100 Patents (Medical) associated with BYON-4413
Login to view more data
100 Deals associated with BYON-4413
Login to view more data
R&D Status
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Acute Myeloid Leukemia | Phase 1 | ES | 25 Jun 2024 | |
| Acute Myeloid Leukemia | Phase 1 | BE | 25 Jun 2024 | |
| Acute Myeloid Leukemia | Phase 1 | NL | 25 Jun 2024 | |
| Myelodysplastic Syndromes | Phase 1 | BE | 25 Jun 2024 | |
| Myelodysplastic Syndromes | Phase 1 | ES | 25 Jun 2024 | |
| Myelodysplastic Syndromes | Phase 1 | NL | 25 Jun 2024 |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free